Description
The FDA is issuing a notice of intent to sole source a purchase order for one Whole Genome Sequencing instrument. The instrument must meet or exceed the requirements specified in the Statement of Work, which includes using sequencing-by-synthesis next-generation sequencing technology, supporting single-read and paired-end libraries, and having an output range of up to 25 Gigabases. The contractor shall provide a minimum one-year manufacturer's warranty covering all parts, labor, and operational support. The deliverable is expected to be delivered within 60 days after award, and the warranty shall begin upon final government acceptance.
Some key points to consider are:
• The instrument must be capable of supporting existing validated laboratory workflows.
• It must use sequencing-by-synthesis next-generation sequencing technology.
• It must support single-read and paired-end libraries.
• It must have an output range of up to 25 Gigabases.
• It must have a maximum read length of at least 2 × 500 base pairs.
• It must have ≥85% of bases achieving Q30 at 2 × 300bp.
• It must have RFID or equivalent consumable tracking.
• It must have reagents stored at room temperature.
• It must include onboard data collection and sequence alignment software.
• It must include a monitor and control computer.
• It must be a benchtop system not exceeding 16” × 18” × 26” (W×D×H).